Biopharmaceutical leader Kashiv BioSciences has secured Rs 648 crore in financing from the Union Bank of India to expand its manufacturing site in Pipan, near Ahmedabad. 

The funds will be used to construct one of India’s largest single-use commercial manufacturing facilities for biologics and specialty pharmaceuticals.

The new facility is engineered to reach a total capacity of 50,000L, focusing on high-quality injectables for the US, Canadian, and European markets. 

This expansion aligns with the Gujarat State Biotechnology Policy, aiming to solidify the state's position as a global life-sciences hub while creating hundreds of high-value scientific and technical jobs.